Viewing nowNumesartan Tablet 20mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daehan Newpharm Co., Ltd.

MFDS item code 201507879 · Approved 2015.11.25 · Insurance code 669906510
Treatment of essential hypertension
Essential hypertension is a state of elevated blood pressure that occurs without a specific cause, and this medication helps control blood pressure, reducing the risk of cardiovascular complications and maintaining health. With consistent use, it stabilizes blood pressure levels, alleviating the burden on the heart and blood vessels, thereby improving overall vascular health. Therefore, it is used for the treatment of essential hypertension.
1. Adults The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective circulating blood volume (Intravascular volume depletion) (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. 2. Elderly patients No dose adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
The safety and efficacy in children have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to any component of this medication, pregnant women, and breastfeeding women should not take it, and it is also safe for patients undergoing kidney dialysis, those with severe liver disease, or those with biliary obstruction. Patients with genetic issues such as lactose intolerance should avoid taking this medication due to the lactose it contains. Patients with low blood volume or low body sodium may experience symptoms of hypotension when taking this medication for the first time, so their condition should be thoroughly checked before taking it and appropriate measures taken if necessary. Patients with impaired kidney function should have their kidney function monitored periodically while taking this medication, and it is not recommended for patients with severe kidney impairment or kidney transplant recipients. Particularly for patients with issues in kidney blood vessels, care should be taken as kidney function deterioration may occur. This medication can increase potassium levels, so patients with heart or kidney diseases should regularly monitor their serum potassium concentration. Patients with aortic stenosis, mitral stenosis, or obstructive heart disease should be especially cautious when taking this medication. Due to its blood pressure-lowering action, dizziness may occur, so caution should be exercised when driving or operating hazardous machinery. The antihypertensive effects of this medication may vary among certain ethnic groups, so individual responses should be monitored. Dizziness, headache, palpitations, abdominal pain, rash, and other symptoms may occur during use, and serious side effects such as liver function abnormalities or angioedema have been reported rarely. If symptoms such as chronic diarrhea, abdominal pain, or vomiting persist, discontinuation of the medication and consultation with a doctor are advised. When taking other antihypertensives, potassium supplements, diuretics, etc., the risk of side effects may increase due to interactions, so patients should inform their doctors and take caution. Pregnant women should avoid taking this medication for the health of the fetus, and breastfeeding women should consider cessation of breastfeeding as adverse reactions may occur in infants. The safety of this medication in children has not been established; therefore, it should be used cautiously in children. In case of overdose, symptoms such as hypotension, palpitations, bradycardia may appear, so if such symptoms occur, immediate medical assistance should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from exposure to air or moisture. The appropriate storage temperature is between 1°C and 25°C in a cool place.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Daehan Newpharm Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.